Unraveling the role of Epac1-SOCS3 signaling in the development of neonatal-CRD-induced visceral hypersensitivity in rats.

Abstract

AIMS:

Visceral hypersensitivity in irritable bowel syndrome (IBS) is widespread, but effective therapies for it remain elusive. As a canonical anti-inflammatory protein, suppressor of cytokine signaling 3 (SOCS3) reportedly relays exchange protein 1 directly activated by cAMP (Epac1) signaling and inhibits the intracellular response to inflammatory cytokines. Despite the inhibitory effect of SOCS3 on the pro-inflammatory response and neuroinflammation in PVN, the systematic investigation of Epac1-SOCS3 signaling involved in visceral hypersensitivity remains unknown. This study aimed to explore Epac1-SOCS3 signaling in the activity of hypothalamic paraventricular nucleus (PVN) corticotropin-releasing factor (CRF) neurons and visceral hypersensitivity in adult rats experiencing neonatal colorectal distension (CRD).

METHODS:

Rats were subjected to neonatal CRD to simulate visceral hypersensitivity to investigate the effect of Epac1-SOCS3 signaling on PVN CRF neurons. The expression and activity of Epac1 and SOCS3 in nociceptive hypersensitivity were determined by western blot, RT-PCR, immunofluorescence, radioimmunoassay, electrophysiology, and pharmacology.

RESULTS:

In neonatal-CRD-induced visceral hypersensitivity model, Epac1 and SOCS3 expressions were downregulated and IL-6 levels elevated in PVN. However, infusion of Epac agonist 8-pCPT in PVN reduced CRF neuronal firing rates, and overexpression of SOCS3 in PVN by AAV-SOCS3 inhibited the activation of PVN neurons, reduced visceral hypersensitivity, and precluded pain precipitation. Intervention with IL-6 neutralizing antibody also alleviated the visceral hypersensitivity. In naïve rats, Epac antagonist ESI-09 in PVN increased CRF neuronal firing. Consistently, genetic knockdown of Epac1 or SOCS3 in PVN potentiated the firing rate of CRF neurons, functionality of HPA axis, and sensitivity of visceral nociception. Moreover, pharmacological intervention with exogenous IL-6 into PVN simulated the visceral hypersensitivity.

CONCLUSIONS:

Inactivation of Epac1-SOCS3 pathway contributed to the neuroinflammation accompanied by the sensitization of CRF neurons in PVN, precipitating visceral hypersensitivity and pain in rats experiencing neonatal CRD.

• Authors: Si-Ting Huang, Bin-Bin Chen, Zhi-Jing Song, Hui-Li Tang, Rong Hua, Yong-Mei Zhang
• Journal: CNS neuroscience & therapeutics (CNS Neurosci Ther) Vol. 28 Issue 9 Pg. 1393-1408 (09 2022) ISSN: 1755-5949 [Electronic] England
• PMID: 35702948 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2022 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.

Chemical References

• Guanine Nucleotide Exchange Factors
• Interleukin-6
• Rapgef3 protein, rat
• Socs3 protein, rat
• Suppressor of Cytokine Signaling 3 Protein
• Corticotropin-Releasing Hormone

Topics

• Animals
• Colonic Diseases (genetics, metabolism, pathology)
• Corticotropin-Releasing Hormone (metabolism)
• Dilatation, Pathologic (complications, genetics, metabolism)
• Disease Models, Animal
• Guanine Nucleotide Exchange Factors (genetics, metabolism)
• Humans
• Hyperalgesia (etiology, genetics, metabolism)
• Hypothalamo-Hypophyseal System (metabolism)
• Infant, Newborn
• Infant, Newborn, Diseases (genetics, metabolism)
• Interleukin-6 (metabolism)
• Intestinal Diseases (complications, genetics, metabolism, pathology)
• Neuroinflammatory Diseases (genetics, metabolism)
• Neurons (metabolism)
• Pain
• Paraventricular Hypothalamic Nucleus (metabolism)
• Pituitary-Adrenal System (metabolism)
• Rats
• Rats, Sprague-Dawley
• Rectal Diseases (genetics, metabolism, pathology)
• Signal Transduction
• Suppressor of Cytokine Signaling 3 Protein (genetics, metabolism)
• Visceral Pain (etiology, genetics, metabolism)